Product NDC: | 27437-110 |
Proprietary Name: | ANTARA |
Non Proprietary Name: | FENOFIBRATE |
Active Ingredient(s): | 130 mg/1 & nbsp; FENOFIBRATE |
Administration Route(s): | ORAL |
Dosage Form(s): | CAPSULE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 27437-110 |
Labeler Name: | LUPIN PHARMA |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA021695 |
Marketing Category: | NDA |
Start Marketing Date: | 20090925 |
Package NDC: | 27437-110-06 |
Package Description: | 30 CAPSULE in 1 BOTTLE (27437-110-06) |
NDC Code | 27437-110-06 |
Proprietary Name | ANTARA |
Package Description | 30 CAPSULE in 1 BOTTLE (27437-110-06) |
Product NDC | 27437-110 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | FENOFIBRATE |
Dosage Form Name | CAPSULE |
Route Name | ORAL |
Start Marketing Date | 20090925 |
Marketing Category Name | NDA |
Labeler Name | LUPIN PHARMA |
Substance Name | FENOFIBRATE |
Strength Number | 130 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Peroxisome Proliferator Receptor alpha Agonist [EPC],Peroxisome Proliferator-activated Receptor alpha Agonists [MoA],PPAR alpha [Chemical/Ingredient] |